Witnessing the stock’s movement on the chart, on Wednesday, Applied Therapeutics Inc (NASDAQ: APLT) had a quiet start as it plunged -13.23% to $0.38, before settling in for the price of $0.44 at the close. Taking a more long-term approach, APLT posted a 52-week range of $0.29-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -19.09%. Meanwhile, its Annual Earning per share during the time was 26.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 23.30%. This publicly-traded company’s shares outstanding now amounts to $141.58 million, simultaneously with a float of $117.55 million. The organization now has a market capitalization sitting at $53.50 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4389, while the 200-day Moving Average is $3.5156.
Applied Therapeutics Inc (APLT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Applied Therapeutics Inc’s current insider ownership accounts for 16.97%, in contrast to 74.93% institutional ownership. According to the most recent insider trade that took place on Mar 04 ’25, this organization’s Chief Medical Officer sold 10,366 shares at the rate of 0.44, making the entire transaction reach 4,561 in total value, affecting insider ownership by 890,409. Preceding that transaction, on Mar 04 ’25, Company’s insider sold 14,502 for 0.44, making the whole transaction’s value amount to 6,381. This particular insider is now the holder of 390,459 in total.
Applied Therapeutics Inc (APLT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
Applied Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 23.30% and is forecasted to reach -0.41 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 24.56% through the next 5 years, which can be compared against the 26.57% growth it accomplished over the previous five years trading on the market.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Therapeutics Inc (APLT). It’s Quick Ratio in the last reported quarter now stands at 3.00. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 198.15.
In the same vein, APLT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.43, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -0.41 at the market close of one year from today.
Technical Analysis of Applied Therapeutics Inc (APLT)
Going through the that latest performance of [Applied Therapeutics Inc, APLT]. Its last 5-days volume of 5.58 million indicated improvement to the volume of 3.24 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 15.73% While, its Average True Range was 0.0676.
Raw Stochastic average of Applied Therapeutics Inc (APLT) in the period of the previous 100 days is set at 12.12%, which indicates a major rise in contrast to 2.95% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 187.28% that was higher than 114.43% volatility it exhibited in the past 100-days period.
